Effectiveness comparisons between tofacitinib, filgotinib and upadacitinib in ulcerative colitis: results from the JAKARTA real-world evidence multicenter study

被引：0
|
作者：
Buisson, A. [1 ]
Treton, X. [2 ]
Nachury, M. [3 ]
Uzzan, M. [4 ]
Bouguen, G. [5 ]
Hamadidi, A. Banana [1 ]
Amiot, A. [6 ]
Serrero, M. [7 ]
Fumery, M. [8 ]
Caillo, L. [9 ]
Hupe, M. [10 ]
Pereira, B. [1 ]
Altwegg, R. [11 ]
机构：
[1] CHU Clermont Ferrand, IBD Unit, Clermont Ferrand, France
[2] Paris IBD Ctr, IBD Unit, Paris, France
[3] IBD Unit, CHRU Lille, Lille, France
[4] CHU Creteil, IBD Unit, Creteil, France
[5] CHU Rennes, IBD Unit, Rennes, France
[6] AP HP Kremlin Bicetre, IBD Unit, Paris, France
[7] AP HM, IB Unit, Marseille, France
[8] CHU Amiens, IBD Unit, Amiens, France
[9] CHU Nimes, IBD Unit, Nimes, France
[10] CHU Grenoble, IBD Unit, Grenoble, France
[11] CHU Montpellier, IBD Unit, Montpellier, France
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0785
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0611
引用
收藏
页码：i1212 / i1212
页数：1
相关论文
共 50 条
  • [31] Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience
    Honap, Sailish
    Chee, Desmond
    Chapman, Thomas P.
    Patel, Mehul
    Kent, Alexandra J.
    Ray, Shuvra
    Sharma, Esha
    Kennedy, James
    Cripps, Sarah
    Walsh, Alissa
    Goodhand, James R.
    Ahmad, Tariq
    Satsangi, Jack
    Irving, Peter M.
    Kennedy, Nicholas A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (10): : 1385 - 1393
  • [32] Australian multicenter real-world experience of upadacitinib induction therapy for moderate to severe ulcerative colitis
    Gilmore, R.
    Fernandes, R.
    Hartley, I.
    Arzivian, A.
    Leong, R.
    Andrew, B.
    Vasudevan, A.
    Greeve, T.
    Moore, G.
    Kim, S.
    Lightowler, D.
    Singh, A.
    Mahy, G.
    Mithanthaya, A.
    Venugopal, K.
    Han, S.
    Bryant, R.
    Corte, C.
    Ding, J. N.
    An, Y-K
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 185 - 186
  • [33] Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
    Mocci Md Frcp, G.
    Costa, F.
    Ceccarelli, L.
    Savarino, E.
    Mucherino, C.
    Marzo, M.
    Scaldaferri, F.
    Napolitano, D.
    Pugliese, D.
    Gravina, A. G.
    Pellegrino, R.
    Spagnuolo, R.
    Cuomo, A.
    Maconi, G.
    Bertani, L.
    Bodini, G.
    Orru, G.
    Piergallini, S.
    Scarcelli, A.
    Capone, P.
    Cortellini, F.
    Rodino, S.
    Vespere, G.
    Gaiani, F.
    Pagnini, C.
    Graziani, G.
    Allegretta, L.
    Ferronato, A.
    Ribaldone, D. G.
    Aragona, G.
    Forti, G.
    Di Fonzo, M.
    Iacopini, F.
    Pica, R.
    Onidi, M. F.
    Usai Satta, P.
    Elisei, W.
    Picchio, M.
    Papa, A.
    Tursi, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1946 - i1946
  • [34] Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
    Deepak, Parakkal
    Alayo, Quazim A.
    Khatiwada, Aava
    Lin, Bixuan
    Fenster, Marc
    Dimopoulos, Christina
    Bader, Geoffrey
    Weisshof, Roni
    Jacobs, Michael
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    Christophi, George P.
    Patel, Anish
    Hirten, Robert P.
    Colombel, Jean-Frederic
    Rubin, David T.
    Ha, Christina
    Beniwal-Patel, Poonam
    Ungaro, Ryan C.
    Syal, Gaurav
    Pekow, Joel
    Cohen, Benjamin L.
    Yarur, Andres
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1592 - +
  • [35] FILGOTINIB IN ULCERATIVE COLITIS: EARLY REAL-WORLD MULTICENTRE UK EXPERIENCE
    Young, David
    Rahmany, Sohail
    Taylor, Debbie
    Davis, Emma
    Campbell, Roisin
    Hazel, Karl
    Sethi-Arora, Karishma
    Ritchie, Susan
    Dhar, Anjan
    Limdi, Jimmy K.
    Cooney, Rachel
    Seenan, John Paul
    Walsh, Alissa
    Cummings, Fraser
    GASTROENTEROLOGY, 2024, 166 (05) : S831 - S832
  • [36] Real-world experience of tofacitinib in Australia for treatment of ulcerative colitis
    Khoo, E.
    Lee, A.
    Lo, S. W.
    Wright, E.
    Ghaly, S.
    Makanyanga, J.
    Thin, L.
    Fang, W.
    Niewiadomski, O.
    Chung, A.
    Digby-Bell, J.
    Sparrow, M.
    Shelton, E.
    Jakobovits, S.
    Scott, D.
    Ward, M.
    Ardalan, Z. S. M.
    An, Y-K
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 124 - 125
  • [37] Filgotinib in ulcerative colitis: early real-world multicentre UK experience
    Young, D.
    Rahmany, S.
    Taylor, D.
    Davis, E.
    Campbell, R.
    Hazel, K.
    Sethi-Arora, K.
    Ritchie, S.
    Dhar, A.
    Limdi, J.
    Cooney, R.
    Seenan, J. P.
    Walsh, A.
    Cummings, F.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1606 - I1607
  • [38] TOFACITINIB IN ULCERATIVE COLITIS: EARLY REAL-WORLD EXPERIENCE IN SOUTHAMPTON
    Young, David
    Ventress, Esther
    Harris, Richard
    McDonnell, Martin
    Bettey, Marion
    Gwiggner, Markus
    Felwick, Richard
    Smith, Trevor
    Cummings, Fraser
    GUT, 2021, 70 : A130 - A130
  • [39] Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study
    Hoffmann, Peter
    Globig, Anna-Maria
    Thomann, Anne K.
    Grigorian, Maximilian
    Krisam, Johannes
    Hasselblatt, Peter
    Reindl, Wolfgang
    Gauss, Annika
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 13
  • [40] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
    Hong, Simon
    Zullow, Samantha
    Axelrad, Jordan
    Chang, Shannon
    Hudesman, David
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S73 - S74
12345